An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at Washington University School of Medicine in St. Louis. The findings suggest — for the first time in a clinical trial — that early treatment to remove amyloid plaques from the brain many years before…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply